“…The COMT gene, mapped to chromosome 22q11, contains a functional polymorphism (COMT Val 158 Met) resulting in two common variants of the enzyme (Val and Met) corresponding to high-and low-activity enzyme, respectively. Increased COMT activity may result in a combination of (i) reduced dopamine neurotransmission in the prefrontal cortex, hypothesized to result in poorer performance of frontally mediated cognitive tasks, in particular working memory and attention (Egan et al, 2001;Meyer-Lindenberg et al, 2005;Rosa et al, 2004) and (ii) increased levels of meso-limbic dopamine signaling hypothesized to result in increased risk for delusions and hallucinations, the core symptoms of psychosis (Akil et al, 2003;Bilder et al, 2004). The work to date therefore suggests that COMT genotype, psychometric psychosis liability, and being a patient with a psychotic disorder moderate the effect of cannabis on psychosis outcomes in the community (Caspi et al, 2005;Henquet et al, 2005a) and that differential sensitivity to cannabis not only involves the positive symptoms of psychosis, but also cognition, in particular memory (D'Souza et al, 2005).…”